Could Ocugen Be a Millionaire Maker Stock? [The Motley Fool]
Ocugen, Inc. (OCGN)
Company Research
Source: The Motley Fool
If you invested $0,000 inOcugen(NASDAQ:OCGNOcugen is in a partnership with India's Bharat Biotech to develop its coronavirus vaccine, COVAXIN. Recently, COVAXIN demonstrated the ability to provide protection against all three Brazil, U.K., and Indian coronavirus variants.In an interim phase clinical trial, the vaccine demonstrated 00% efficacy against severe cases of COVID-9. The vaccine is already authorized for use in India. Ocugen plans to commercialize its vaccines in the U.S., but is facingextreme headwindsImage source: Getty ImagesWhat's the problem?A big issue for Ocugen is that it has all of its eggs in one basket. The company does not own COVAXIN -- it merely owns its U.S. (and only U.S.) licensing rights. Therefore, the firm's success depends entirely on whether or not it can commercialize the vaccine in time. It has no product revenue, and its gene therapy research candidates are only in the preclinical phase.President Biden has announced that the nation is on track to vacc
Show less
Read more
Impact Snapshot
Event Time:
OCGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCGN alerts
High impacting Ocugen, Inc. news events
Weekly update
A roundup of the hottest topics
OCGN
News
- Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock [Yahoo! Finance]Yahoo! Finance
- ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGNPR Newswire
- Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common StockGlobeNewswire
- INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $500,000 to Contact the FirmAccesswire
- OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!GlobeNewswire
OCGN
Earnings
- 11/9/23 - Beat
OCGN
Sec Filings
- 5/10/24 - Form 8-A12G
- 5/10/24 - Form 8-K
- 5/2/24 - Form EFFECT
- OCGN's page on the SEC website